107 related articles for article (PubMed ID: 18661355)
1. Thrombospondin-1 in differentiated thyroid cancer: Dr. Jekyll and Mr. Hyde.
Ghoneim C; Soula-Rothhut M; Rothhut B
Connect Tissue Res; 2008; 49(3):257-60. PubMed ID: 18661355
[TBL] [Abstract][Full Text] [Related]
2. Hepatocyte growth factor (HGF) downregulates thrombospondin 1 (TSP-1) expression in thyroid papillary carcinoma cells.
Scarpino S; Di Napoli A; Taraboletti G; Cancrini A; Ruco LP
J Pathol; 2005 Jan; 205(1):50-6. PubMed ID: 15526350
[TBL] [Abstract][Full Text] [Related]
3. Thrombospondin-1 enhances human thyroid carcinoma cell invasion through urokinase activity.
Sid B; Langlois B; Sartelet H; Bellon G; Dedieu S; Martiny L
Int J Biochem Cell Biol; 2008; 40(9):1890-900. PubMed ID: 18321763
[TBL] [Abstract][Full Text] [Related]
4. Activating transcription factor-1-mediated hepatocyte growth factor-induced down-regulation of thrombospondin-1 expression leads to thyroid cancer cell invasion.
Ghoneim C; Soula-Rothhut M; Blanchevoye C; Martiny L; Antonicelli F; Rothhut B
J Biol Chem; 2007 May; 282(21):15490-7. PubMed ID: 17409099
[TBL] [Abstract][Full Text] [Related]
5. The expression and role of serum response factor in papillary carcinoma of the thyroid.
Kim HJ; Kim KR; Park HS; Jang KY; Chung MJ; Shong M; Moon WS
Int J Oncol; 2009 Jul; 35(1):49-55. PubMed ID: 19513551
[TBL] [Abstract][Full Text] [Related]
6. Expression and secretion of endostatin in thyroid cancer.
Hoffmann S; Wunderlich A; Lingelbach S; Musholt PB; Musholt TJ; von Wasielewski R; Zielke A
Ann Surg Oncol; 2008 Dec; 15(12):3601-8. PubMed ID: 18818971
[TBL] [Abstract][Full Text] [Related]
7. The tumor suppressor PTEN inhibits EGF-induced TSP-1 and TIMP-1 expression in FTC-133 thyroid carcinoma cells.
Soula-Rothhut M; Coissard C; Sartelet H; Boudot C; Bellon G; Martiny L; Rothhut B
Exp Cell Res; 2005 Mar; 304(1):187-201. PubMed ID: 15707585
[TBL] [Abstract][Full Text] [Related]
8. Tumor progression: the effects of thrombospondin-1 and -2.
Lawler J; Detmar M
Int J Biochem Cell Biol; 2004 Jun; 36(6):1038-45. PubMed ID: 15094119
[TBL] [Abstract][Full Text] [Related]
9. A germline mutation (A339V) in thyroid transcription factor-1 (TITF-1/NKX2.1) in patients with multinodular goiter and papillary thyroid carcinoma.
Ngan ES; Lang BH; Liu T; Shum CK; So MT; Lau DK; Leon TY; Cherny SS; Tsai SY; Lo CY; Khoo US; Tam PK; Garcia-Barceló MM
J Natl Cancer Inst; 2009 Feb; 101(3):162-75. PubMed ID: 19176457
[TBL] [Abstract][Full Text] [Related]
10. Modulation of growth factor action by the extracellular matrix.
Oehrl W; Panayotou G
Connect Tissue Res; 2008; 49(3):145-8. PubMed ID: 18661330
[TBL] [Abstract][Full Text] [Related]
11. Metformin decreases angiogenesis via NF-kappaB and Erk1/2/Erk5 pathways by increasing the antiangiogenic thrombospondin-1.
Tan BK; Adya R; Chen J; Farhatullah S; Heutling D; Mitchell D; Lehnert H; Randeva HS
Cardiovasc Res; 2009 Aug; 83(3):566-74. PubMed ID: 19414528
[TBL] [Abstract][Full Text] [Related]
12. The role of thrombospondin-1 in human disease.
Esemuede N; Lee T; Pierre-Paul D; Sumpio BE; Gahtan V
J Surg Res; 2004 Nov; 122(1):135-42. PubMed ID: 15522326
[TBL] [Abstract][Full Text] [Related]
13. Phosphorylated insulin like growth factor-I receptor expression and its clinico-pathological significance in histologic subtypes of human thyroid cancer.
Chakravarty G; Santillan AA; Galer C; Adams HP; El-Naggar AK; Jasser SA; Mohsin S; Mondal D; Clayman GL; Myers JN
Exp Biol Med (Maywood); 2009 Apr; 234(4):372-86. PubMed ID: 19176870
[TBL] [Abstract][Full Text] [Related]
14. Thrombospondin 1: a multifunctional protein implicated in the regulation of tumor growth.
Sid B; Sartelet H; Bellon G; El Btaouri H; Rath G; Delorme N; Haye B; Martiny L
Crit Rev Oncol Hematol; 2004 Mar; 49(3):245-58. PubMed ID: 15036264
[TBL] [Abstract][Full Text] [Related]
15. COX-2 is induced by HGF stimulation in Met-positive thyroid papillary carcinoma cells and is involved in tumour invasiveness.
Scarpino S; Duranti E; Stoppacciaro A; Pilozzi E; Natoli G; Sciacchitano S; Luciani E; Ruco L
J Pathol; 2009 Aug; 218(4):487-94. PubMed ID: 19391129
[TBL] [Abstract][Full Text] [Related]
16. Analysis of deregulated miRNAs is helpful to distinguish poorly differentiated thyroid carcinoma from papillary thyroid carcinoma.
Schwertheim S; Sheu SY; Worm K; Grabellus F; Schmid KW
Horm Metab Res; 2009 Jun; 41(6):475-81. PubMed ID: 19370508
[TBL] [Abstract][Full Text] [Related]
17. Id1 is down-regulated by hepatocyte growth factor via ERK-dependent and ERK-independent signaling pathways, leading to increased expression of p16INK4a in hepatoma cells.
Ushio K; Hashimoto T; Kitamura N; Tanaka T
Mol Cancer Res; 2009 Jul; 7(7):1179-88. PubMed ID: 19567783
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathologic evaluation of immunohistochemical CD147 and MMP-2 expression in differentiated thyroid carcinoma.
Tan H; Ye K; Wang Z; Tang H
Jpn J Clin Oncol; 2008 Aug; 38(8):528-33. PubMed ID: 18664479
[TBL] [Abstract][Full Text] [Related]
19. Expression and regulation of thrombospondin-1 by human endometrial stromal cells.
Kawano Y; Nakamura S; Nasu K; Fukuda J; Narahara H; Miyakawa I
Fertil Steril; 2005 Apr; 83(4):1056-9. PubMed ID: 15820829
[TBL] [Abstract][Full Text] [Related]
20. Follicular variant of papillary thyroid carcinoma with unusual late metastasis to the mandible and the scapula.
Liu L; Venkataraman G; Salhadar A
Pathol Int; 2007 May; 57(5):296-8. PubMed ID: 17493179
[No Abstract] [Full Text] [Related]
[Next] [New Search]
